Skip to main content
. 2018 Sep 29;10(10):365. doi: 10.3390/cancers10100365

Table 3.

Inhibitory concentrations of drugs/inhibitors used in this study.

Drug SKOV-3 NGP-127
IC20 (µM) IC50 (µM) IC20 (µM) IC50 (µM)
Afuresertib 2.7 17 8 19
FLI-06 1.5 2 11 20
U73122 3 3.2 1 3.5
Sapitinib 11 37 4.2 ≥40
Sorafenib * 9.6 5.5
Pazopanib * ≥50 12
Sunitinib * 3 3.1
Temsirolimus * 17 11.8
Everolimus * 17.6 15.5

* Data taken from a past paper [8].